These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7779103)

  • 1. Telomere shortening in chronic liver diseases.
    Kitada T; Seki S; Kawakita N; Kuroki T; Monna T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):33-9. PubMed ID: 7779103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere reduction in human liver tissues with age and chronic inflammation.
    Aikata H; Takaishi H; Kawakami Y; Takahashi S; Kitamoto M; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Exp Cell Res; 2000 May; 256(2):578-82. PubMed ID: 10772830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
    Plentz RR; Caselitz M; Bleck JS; Gebel M; Flemming P; Kubicka S; Manns MP; Rudolph KL
    Hepatology; 2004 Jul; 40(1):80-6. PubMed ID: 15239089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
    Wiemann SU; Satyanarayana A; Tsahuridu M; Tillmann HL; Zender L; Klempnauer J; Flemming P; Franco S; Blasco MA; Manns MP; Rudolph KL
    FASEB J; 2002 Jul; 16(9):935-42. PubMed ID: 12087054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case.
    Joske RA; Laurence BH; Matz LR
    Gastroenterology; 1972 Mar; 62(3):441-4. PubMed ID: 4334824
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD.
    Nakajima T; Moriguchi M; Katagishi T; Sekoguchi S; Nishikawa T; Takashima H; Kimura H; Minami M; Itoh Y; Kagawa K; Tani Y; Okanoue T
    Liver Int; 2006 Feb; 26(1):23-31. PubMed ID: 16420506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
    Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
    Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas.
    Paradis V; Youssef N; Dargère D; Bâ N; Bonvoust F; Deschatrette J; Bedossa P
    Hum Pathol; 2001 Mar; 32(3):327-32. PubMed ID: 11274643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
    Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
    Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active chronic hepatitis and liver cirrhosis observed in 3 siblings in a family with liver cirrhosis dominance--observations on familial cryptogenic cirrhosis].
    Obayashi A; Yoshinaka M; Goto N; Nakamura Y; Aoki S
    Nihon Rinsho; 1969 Oct; 27(10):2592-601. PubMed ID: 5389809
    [No Abstract]   [Full Text] [Related]  

  • 14. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
    Plentz RR; Schlegelberger B; Flemming P; Gebel M; Kreipe H; Manns MP; Rudolph KL; Wilkens L
    Hepatology; 2005 Sep; 42(3):522-6. PubMed ID: 16116624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
    J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
    Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.
    Honda M; Kaneko S; Sakai A; Unoura M; Murakami S; Kobayashi K
    Hepatology; 1994 Nov; 20(5):1144-51. PubMed ID: 7927245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis.
    Isokawa O; Suda T; Aoyagi Y; Kawai H; Yokota T; Takahashi T; Tsukada K; Shimizu T; Mori S; Abe Y; Suzuki Y; Nomoto M; Mita Y; Yanagi M; Igarashi H; Asakura H
    Hepatology; 1999 Aug; 30(2):408-12. PubMed ID: 10421648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.